These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6361067)

  • 1. Myasthenia gravis. Antibodies to skeletal muscle cell surface antigens.
    Gilhus NE; Aarli JA; Matre R
    J Neuroimmunol; 1983 Dec; 5(3):239-49. PubMed ID: 6361067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myasthenia gravis: the specificities of skeletal muscle and thymus antibodies.
    Gilhus NE; Aarli JA; Matre R
    Acta Neurol Scand; 1983 Nov; 68(5):328-36. PubMed ID: 6364682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenia gravis: difference between thymoma-associated antibodies and cross-striational skeletal muscle antibodies.
    Gilhus NE; Aarli JA; Matre R
    Neurology; 1984 Feb; 34(2):246-9. PubMed ID: 6363971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabbit antiserum to a citric acid extract of human skeletal muscle staining thymomas from myasthenia gravis patients.
    Gilhus NE; Aarli JA; Christensson B; Matre R
    J Neuroimmunol; 1984 Nov; 7(1):55-64. PubMed ID: 6389592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reactivity of the antistriational antibodies associated with thymoma and myasthenia gravis.
    Peers J; McDonald BL; Dawkins RL
    Clin Exp Immunol; 1977 Jan; 27(1):66-73. PubMed ID: 321160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of antibodies to citric acid extract of skeletal muscle (CAE-ab) in the sera of patients with myasthenia gravis using indirect hemagglutination].
    Ma W
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Jun; 23(3):143-5, 189. PubMed ID: 2390884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal muscle antibodies in patients with a thymic tumour but without myasthenia gravis.
    Gilhus NE; Aarli JA; Janzen RW; Otto HF; Fasske E; Matre R
    J Neuroimmunol; 1985 May; 8(2-3):69-78. PubMed ID: 3998123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to skeletal muscle in myasthenia gravis. Part 1. Diagnostic value for the detection of thymoma.
    Kuks JB; Limburg PC; Horst G; Dijksterhuis J; Oosterhuis HJ
    J Neurol Sci; 1993 Nov; 119(2):183-8. PubMed ID: 8277333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin.
    Aarli JA; Stefansson K; Marton LS; Wollmann RL
    Clin Exp Immunol; 1990 Nov; 82(2):284-8. PubMed ID: 2242609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymoma-specific antibodies in sera from patients with myasthenia gravis demonstrated by indirect haemagglutination.
    Aarli JA; Lefvert AK; Tönder O
    J Neuroimmunol; 1981 Dec; 1(4):421-7. PubMed ID: 7346525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myasthenia gravis: cross-striational fluorescence of muscle fibers mediated by Fc fragments.
    Aarli JA; Closs O
    J Immunol; 1972 Aug; 109(2):271-4. PubMed ID: 4558536
    [No Abstract]   [Full Text] [Related]  

  • 12. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance.
    Romi F; Skeie GO; Gilhus NE; Aarli JA
    Arch Neurol; 2005 Mar; 62(3):442-6. PubMed ID: 15767509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against nicotinic acetylcholine receptor and skeletal muscle in human and experimental myasthenia gravis.
    Aarli JA; Mattsson C; Heilbronn E
    Scand J Immunol; 1975; 4(8):849-52. PubMed ID: 1215840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without myasthenia gravis: relation to the onset of myasthenia gravis.
    Ohta M; Itoh M; Hara H; Itoh N; Nishitani H; Hayashi K; Ohta K
    Clin Chim Acta; 1991 Sep; 201(3):201-5. PubMed ID: 1756593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to skeletal muscle in myasthenia gravis. Part 2. Prevalence in non-thymoma patients.
    Kuks JB; Limburg PC; Horst G; Oosterhuis HJ
    J Neurol Sci; 1993 Dec; 120(1):78-81. PubMed ID: 8289082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization and properties of an acid-soluble muscle antigen reacting with antibodies in myasthenia gravis sera.
    Aarli JA
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1972; 80(3):453-9. PubMed ID: 4114938
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies in myasthenia gravis. Incidence of muscle-precipitating antibodies correlated with positive immunofluorescence.
    Lang RW; Kornfeld P; Weiner LB; Osserman KE
    Am J Clin Pathol; 1969 Feb; 51(2):238-44. PubMed ID: 4974864
    [No Abstract]   [Full Text] [Related]  

  • 18. An enzyme-linked immunosorbent assay for antistriational antibodies associated with myasthenia gravis and thymoma: comparison with indirect immunofluorescence.
    Carrano JA; Swanson NR; Dawkins RL
    J Immunol Methods; 1983 May; 59(3):301-14. PubMed ID: 6343491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme-linked immunosorbent assay for detection of antibodies to extractable muscle antigens in myasthenia gravis.
    Viana VS; Bueno C; Marchiori PE; Oliveira RM; Assis JL; Scaff M; Cossermelli W
    Acta Neurol Scand; 1986 Jun; 73(6):599-601. PubMed ID: 3751500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CA-antibody: an immunological marker of thymic neoplasia in myasthenia gravis?
    Aarli JA; Gilhus NE; Hofstad H
    Acta Neurol Scand; 1987 Jul; 76(1):55-7. PubMed ID: 3630645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.